
Vol. 53, No. 2, 2006
Free Abstract
Article (References)
Article (PDF 127 KB)
Original Paper
Analysis of Synapsin III -196 Promoter Mutation in Schizophrenia and Bipolar Disorder
Herbert M. Lachmana, Pavla Stopkovab, Demitri F. Papolosa, Erika Pedrosaa, Benjamin Margolisa, Maryam Rafael Aghalara, Takuya Saitoa
aDepartment of Psychiatry and Behavioral Sciences, Division of Psychiatry Research, Albert Einstein College of Medicine, Bronx, N.Y., USA, and bPsychiatric Center, Prague, Czech Republic
Address of Corresponding Author
Neuropsychobiology 2006;53:57-62 (DOI: 10.1159/000091720)
Key Words
- POU family of transcription factors
- Oct-1
- Chromosome 22
- 22q12-q13
- Schizophrenia
- Synaptic vesicle
- Octamer
Abstract
Background: The 22q13-linked gene synapsin III is a positional candidate gene for schizophrenia (SZ). One interesting synapsin III single nucleotide polymorphism (SNP), -196G/A, has been identified in the promoter region. The -196A allele results in a 6/8 base match to the core recognition octamer sequence for Oct-1, a member of the POU family of transcription factors. Objective: To determine whether or not the -196 SNP is associated with either SZ or bipolar disorder (BD). Methods: A case control comparison was used to determine whether or not differences in allele or genotype distribution occurred in patients with SZ and BD. Electromobility gel shift assay (EMSA) was used to determine whether the -196 SNP affected protein binding. Results: A trend towards significance was detected when the allele distribution was analyzed in Caucasian patients with SZ (n = 145; 191 controls) and a cohort of subjects from the Czech Republic with BD (n = 82; 94 controls). No association was found in bipolar patients from the United States (n = 127) or in African-American patients with SZ (n = 124; 133 controls). EMSA showed that the region encompassing the -196 SNP binds to a brain protein in an allele-specific manner. Conclusions: These data, while inconclusive, suggest that -196 SNP should be further investigated as a candidate for 22q13-linked SZ. Copyright © 2006 S. Karger AG, Basel
Author Contacts
Herbert M. Lachman Albert Einstein College of Medicine 1300 Morris Park Avenue Bronx, N.Y. 10461 (USA) Tel. +1 718 430 2428, Fax +1 718 430 8772, E-Mail Lachman@aecom.yu.edu
Article Information
Received: December 9, 2004
Accepted after revision: July 24, 2005
Published online: February 23, 2006
Number of Print Pages : 6
Number of Figures : 0, Number of Tables : 4, Number of References : 37 |
|

|

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service. |
|
|